Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: gene mutation
- Type of information:
- other: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- not yet defined
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- NON-CONFIDENTIAL NAME OF SUBSTANCE:
Name of the substance on which the test has been performed: refer to the attached document
This test will be used in read-across on the target substance Reactive Orange 16 (EC: 701-348-2).
CONSIDERATIONS THAT THE GENERAL ADAPTATION POSSIBILITIES OF ANNEX XI OF THE REACH REGULATION ARE NOT ADEQUATE TO GENERATE THE NECESSARY INFORMATION
a) This part refers to the available studies on the target substance Reactive Orange 16 (EC: 701-348-2):
- Available GLP studies: not available.
- Available non-GLP studies: not available.
- Historical human data: not available.
- (Q)SAR: not available.
- Weight of evidence: not available.
- Grouping and read-across:
b) This part refers to the available studies on the analogue substance that were used in read across to cover the endpoint of genotoxicity of Reactive Orange 16 (EC: 701-348-2):
In vivo alkaline Comet Assay (OECD 489)
CONSIDERATIONS THAT THE SPECIFIC ADAPTATION POSSIBILITIES OF ANNEXES VI TO X (AND COLUMN 2 THEREOF) OF THE REACH REGULATION ARE NOT ADEQUATE TO GENERATE THE NECESSARY INFORMATION:
Under Annex VIII, Section 8.4, column 2 of REACH, the performance of an appropriate in vivo somatic cell genotoxicity study must be considered if there is a positive result in any of the in vitro genotoxicity studies in Annex VII or VIII.
Guidance on information requirements R7a, section 7.7.6 (2017), states that regarding Annex VIII, when both the mammalian cell tests are negative but there was a positive result in the bacterial test, it will be necessary to decide whether any further testing is needed on a case-by-case basis. For example, suspicion that a unique positive response observed in the bacterial test was due to a specific bacterial metabolism of the test substance could be explored further by investigation in vitro. Alternatively, an in vivo test may be required. The choice of the appropriate in vivo study is triggered by the availability of reliable cytogenicity studies, either in vitro or in vivo, covering the endpoint. In fact,
a. If the test results of the available cytogenicity test(s) are negative, an in vivo mammalian alkaline comet assay (test method: OECD TG 489) in rats, or if justified, in other rodent species, oral route, on the following tissues, liver, glandular stomach and duodenum needs to be performed
b. If the test results of the available cytogenicity test(s) are positive, an in vivo mammalian alkaline comet assay (test method: OECD TG 489) combined with in vivo mammalian erythrocyte micronucleus test (test method: OECD TG 474) in rats, or if justified, in other rodent species, oral route needs to be performed. For the In vivo mammalian alkaline comet assay the following tissues shall be analysed: liver, glandular stomach and duodenum
The submitted dossier Reactive Orange 16 EC 701-348-2 contains results for the in vitro gene mutation study in bacteria, following OECD 471, which raises the concern for in vivo gene mutation, since it shows positive results (i.e., an increment of the number of revertants for strain WP2 uvrA with S9 mix at concentrations > 1000 ug/plate with Prival modification and pre-incubation).
An in vitro mammalian chromosome aberration test OECD 473, performed on an analogue substance is inserted, which was considered to fulfill the information requirement. The tested substance resulted non-clastogenic to cultured human peripheral blood lymphocytes, under the experimental conditions. Moreover, an in vivo chromosomal aberration OECD 475 on the same analogue substance, is submitted and the substance resulted not mutagenic in bone marrow cells of the Chinese hamster under the experimental conditions. Based on the considerations reported in the read across justification, same results can be applied also to Reactive Orange 16 and cytogenicity can be considered overall negative.
Therefore, by summarizing all the above available information, an in vivo mammalian alkaline Comet Assay needs to be performed on analogue substance 3 in order to elucidate the in vivo gene mutation potential. The information requirements is fulfilled by applying read across approach from analogue substance 3 , for which an in vivo Comet Assay testing proposal was accepted and will be performed, to target substance Reactive Orange 16.
Both target and analogue substance show positivity to the OECD471 test. Both substances rely for cytogenicity to analogue substance 2, which, as reported in the read across section, in particular based on the submitted toxicokinetics studies, can be used for predicting this genotoxicity potential. Meanwhile, an in vivo alkaline Comet Assay, OECD 489, was requested by the Authorities involving stomach, liver and duodenum as target organs for analogue substance 3.
Altogether the above information on genotoxicity and the considerations reported in the read across document, justify the use of the results of the OECD489 for assessing the potential in vivo gene mutation properties of the target substance Reactive Orange 16.
OECD 489 allows to measure DNA strand breaks, that may result from direct interactions with DNA, alkali labile sites or as a consequence of incomplete excision repair. Therefore, the alkaline comet assay recognizes primary DNA damage that would lead to gene mutations and/or chromosome aberrations, but will also detect DNA damage that may be effectively repaired or lead to cell death. The comet assay can be applied to almost every tissue of an animal from which single cell or nuclei suspensions can be made, including specific site of contact tissues.
CONCLUSIONS
In order to completely assess the in vivo genotoxic potential of Reactive Orange 16, triggered by positive results in an vitro gene mutation study in bacteria and negative results in an in vitro cytogenicity test, a Comet Assay performed on analogue substance is used in read across. The two substances share chemical similarities, phys-chem and toxicological properties that allow the use of the read across methodology.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 022
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 489 (In vivo Mammalian Alkaline Comet Assay)
- GLP compliance:
- yes
- Type of assay:
- mammalian comet assay
Test material
- Reference substance name:
- Similar substance 3
- IUPAC Name:
- Similar substance 3
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
Constituent 1
Test animals
- Species:
- rat
- Sex:
- male
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- No. of animals per sex per dose:
- 5 males/dose
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- yes
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- other: in progress
- Remarks on result:
- other: the test is in read-across from an on going OECD 489 on a similar substance
Applicant's summary and conclusion
- Conclusions:
- study in progress
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.